Clinical Trial Update: Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty [Phase 3]

View source ↗

Summary

Phase 3 trial of oliceridine (TRV130) for moderate to severe acute pain following abdominoplasty completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Oliceridine (Oliceridine)

Snippet

Sponsor: Trevena Inc. | Conditions: Acute Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-10-23